Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR664B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TSPAN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102724197 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
WIPI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP6C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JAZF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPHX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1GALT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORMDL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EFTUD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYLIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HJURP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMCR8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CETN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP78 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on